Taysha
development of a gene therapy for syndrome requires regulated expression of | Taysha
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2020
Slide
30 of 66
Related slides by other companies
Genprex
Investor Presentation
October 2022
advancing gene therapy in large indications | Genprex
Genprex
Investor Presentation
October 2022
tumor suppressor genes deleted during cancer development | Genprex
GreenLight
SPAC
August 2021
developing proof of concept for novel based approach to gene therapy | GreenLight
Genprex
Investor Presentation
November 2024
program highlights | Genprex
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights